In Hela cells, Bim expression was enhanced during the treatment of 4-(3′,3′-Dimethylallyloxy)- 5-methyl-6-methoxy-phthalide (DMMP) to induce the apoptosis that would be a potential therapy for cervical cancer [41]. The gene discussed is BCL2L11; the disease is cervical carcinoma.